Keene & Associates’s Johnson & Johnson JNJ Stock Holding History

Keene & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$2.94M	Buy	20,328 +1,134	+6%	+$176K	2.36%	22
2024 Q3	$3.11M	Buy	19,194 +131	+0.7%	+$20.9K	2.36%	24
2024 Q2	$2.79M	Buy	19,063 +189	+1%	+$28.1K	2.27%	28
2024 Q1	$2.99M	Sell	18,874 -123	-0.6%	-$19.6K	2.23%	30
2023 Q4	$2.98M	Sell	18,997 -70	-0.4%	-$10.7K	2.47%	23
2023 Q3	$2.97M	Buy	19,067 +408	+2%	+$67.3K	2.38%	21
2023 Q2	$3.09M	Buy	18,659 +45	+0.2%	+$7.26K	2.4%	22
2023 Q1	$2.89M	Buy	18,614 +213	+1%	+$34.4K	2.24%	28
2022 Q4	$3.25M	Buy	18,401 +534	+3%	+$92.2K	2.9%	13
2022 Q3	$2.92M	Sell	17,867 -171	-0.9%	-$28.9K	2.68%	9
2022 Q2	$3.2M	Buy	18,038 +106	+0.6%	+$18.9K	3%	11
2022 Q1	$3.18M	Buy	17,932 +1,267	+8%	+$216K	2.59%	22
2021 Q4	$2.85M	Buy	+16,665	New	+$2.73M	2.46%	23

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Keene & Associates's JNJ Position: Q4 2024 in Review

Keene & Associates increased its Johnson & Johnson (JNJ) stake by 5.9% in Q4 2024, buying an estimated $176K and bringing the position to 20,328 shares worth $2.94M. The position accounts for 2.36% of the portfolio, ranked #22.

Keene & Associates first reported a position in JNJ in Q4 2021 and has held it in 13 quarters since. The position peaked at $3.25M in Q4 2022. 4,104 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

Keene & Associates held 20,328 shares of Johnson & Johnson worth $2.94M as of Q4 2024.
Keene & Associates bought 1,134 Johnson & Johnson shares in Q4 2024, an estimated $176K.
Johnson & Johnson made up 2.36% of Keene & Associates's portfolio in Q4 2024, its #22 holding.
Keene & Associates first reported a position in Johnson & Johnson in Q4 2021 and has held it in 13 quarters since.
Keene & Associates's Johnson & Johnson position peaked at $3.25M in Q4 2022.
4,104 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on Keene & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.